104 related articles for article (PubMed ID: 7890253)
1. Effect of acute ethanol ingestion on prolactin in menopausal women using estradiol replacement.
Ginsburg ES; Walsh BW; Shea BF; Gao X; Gleason RE; Feltmate C; Barbieri RL
Gynecol Obstet Invest; 1995; 39(1):47-9. PubMed ID: 7890253
[TBL] [Abstract][Full Text] [Related]
2. The effect of acute ethanol ingestion on estrogen levels in postmenopausal women using transdermal estradiol.
Ginsburg ES; Walsh BW; Gao X; Gleason RE; Feltmate C; Barbieri RL
J Soc Gynecol Investig; 1995; 2(1):26-9. PubMed ID: 9420845
[TBL] [Abstract][Full Text] [Related]
3. The effects of ethanol on the clearance of estradiol in postmenopausal women.
Ginsburg ES; Walsh BW; Shea BF; Gao X; Gleason RE; Barbieri RL
Fertil Steril; 1995 Jun; 63(6):1227-30. PubMed ID: 7750592
[TBL] [Abstract][Full Text] [Related]
4. Effects of alcohol ingestion on estrogens in postmenopausal women.
Ginsburg ES; Mello NK; Mendelson JH; Barbieri RL; Teoh SK; Rothman M; Gao X; Sholar JW
JAMA; 1996 Dec; 276(21):1747-51. PubMed ID: 8940324
[TBL] [Abstract][Full Text] [Related]
5. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
Weissberger AJ; Ho KK; Lazarus L
J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
[TBL] [Abstract][Full Text] [Related]
6. Transdermal estradiol in menopausal women depresses interleukin-6 without affecting other markers of immune response.
Saucedo R; Rico G; Basurto L; Ochoa R; Zárate A
Gynecol Obstet Invest; 2002; 53(2):114-7. PubMed ID: 11961386
[TBL] [Abstract][Full Text] [Related]
7. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
8. Comparison of steady state development and reduction of menopausal symptoms after oral or transdermal delivery of 17-β-estradiol in young healthy symptomatic menopausal women.
Rohr UD; Volko CD; Schindler AE
Horm Mol Biol Clin Investig; 2014 Jun; 18(3):123-36. PubMed ID: 25390008
[TBL] [Abstract][Full Text] [Related]
9. Acute effect of alcohol on estradiol, estrone, progesterone, prolactin, cortisol, and luteinizing hormone in premenopausal women.
Sarkola T; Mäkisalo H; Fukunaga T; Eriksson CJ
Alcohol Clin Exp Res; 1999 Jun; 23(6):976-82. PubMed ID: 10397281
[TBL] [Abstract][Full Text] [Related]
10. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
[TBL] [Abstract][Full Text] [Related]
11. A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms.
Carroll N
J Womens Health (Larchmt); 2010 Jan; 19(1):47-55. PubMed ID: 20088658
[TBL] [Abstract][Full Text] [Related]
12. Hormonal and metabolic effects of transdermal estradiol/progestagen administration in postmenopausal women.
Perrone G; Falaschi P; Capri O; Pastore R; Galoppi P; D'Urso R; Martocchia A; Anelli G; Zichella L
Int J Fertil Menopausal Stud; 1994; 39(4):202-7. PubMed ID: 7951402
[TBL] [Abstract][Full Text] [Related]
13. Effect of transdermal hormone therapy on platelet haemostasis in menopausal women.
Stachowiak G; Pertyński T; Pertyńska-Marczewska M
Ann Agric Environ Med; 2015; 22(1):167-71. PubMed ID: 25780849
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous estrogen replacement therapy. Effects on circulating estrogens, gonadotropins and prolactin.
Holst J; Cajander S; Carlström K; Damber MG; von Schoultz B
Acta Obstet Gynecol Scand; 1983; 62(1):49-53. PubMed ID: 6858624
[TBL] [Abstract][Full Text] [Related]
15. Prolactin serum levels in postmenopausal women receiving long-term hormone replacement therapy.
Foth D; Römer T
Gynecol Obstet Invest; 1997; 44(2):124-6. PubMed ID: 9286727
[TBL] [Abstract][Full Text] [Related]
16. Estrasorb.
Chiechi LM
IDrugs; 2004 Sep; 7(9):860-4. PubMed ID: 15470604
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
O'Sullivan AJ; Ho KK
J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
[TBL] [Abstract][Full Text] [Related]
18. New trends in transdermal technologies: development of the skin patch, Menorest.
Marty JP
Int J Gynaecol Obstet; 1996 Mar; 52 Suppl 1():S17-20. PubMed ID: 8666122
[TBL] [Abstract][Full Text] [Related]
19. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
[TBL] [Abstract][Full Text] [Related]
20. Cyclic hormonal replacement therapy after the menopause: transdermal versus oral treatment.
Cortellaro M; Nencioni T; Boschetti C; Ortolani S; Buzzi F; Francucci B; Caraceni MP; Abelli P; Polvani F; Zanussi C
Eur J Clin Pharmacol; 1991; 41(6):555-9. PubMed ID: 1667755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
